微小RNA：癌症诊断与治疗中的新角色。
MicroRNAs: novel players in cancer diagnosis and therapies.
作者信息
Oom Aaron L, Humphries Brock A, Yang Chengfeng
机构信息
Department of Physiology, Michigan State University, East Lansing, MI 48824, USA.
Department of Physiology, Michigan State University, East Lansing, MI 48824, USA ; Cellular and Molecular Biology Graduate Program, Michigan State University, East Lansing, MI 48824, USA.
出版信息
Biomed Res Int. 2014;2014:959461. doi: 10.1155/2014/959461. Epub 2014 Jul 2.
Abstract
First discovered in 1993, microRNAs (miRNAs) have been one of the hottest research areas over the past two decades. Oftentimes, miRNAs levels are found to be dysregulated in cancer patients. The potential use of miRNAs in cancer therapies is an emerging and promising field, with research finding miRNAs to play a role in cancer initiation, tumor growth, and metastasis. Therefore, miRNAs could become an integral part from cancer diagnosis to treatment in future. This review aims to examine current novel research work on the potential roles of miRNAs in cancer therapies, while also discussing several current challenges and needed future research.
摘要
微小RNA（miRNA）于1993年首次被发现，在过去二十年中一直是最热门的研究领域之一。通常情况下，人们发现癌症患者体内的miRNA水平失调。miRNA在癌症治疗中的潜在应用是一个新兴且有前景的领域，研究发现miRNA在癌症的发生、肿瘤生长和转移中发挥作用。因此，miRNA未来可能会成为癌症诊断到治疗中不可或缺的一部分。这篇综述旨在探讨目前关于miRNA在癌症治疗中潜在作用的新研究工作，同时也讨论当前的一些挑战以及未来所需的研究。
相似文献
1
MicroRNAs: novel players in cancer diagnosis and therapies.
Biomed Res Int. 2014;2014:959461. doi: 10.1155/2014/959461. Epub 2014 Jul 2.
2
Current perspectives on the dysregulated microRNAs in gastric cancer.
Mol Biol Rep. 2020 Sep;47(9):7253-7264. doi: 10.1007/s11033-020-05720-z. Epub 2020 Aug 9.
3
MicroRNAs: tools for cancer diagnostics.
Gut. 2009 Nov;58(11):1546-54. doi: 10.1136/gut.2009.179531.
4
Cross-Roads to Drug Resistance and Metastasis in Breast Cancer: miRNAs Regulatory Function and Biomarker Capability.
Adv Exp Med Biol. 2019;1152:335-364. doi: 10.1007/978-3-030-20301-6_18.
5
MicroRNAs and cancer; an overview.
Curr Pharm Biotechnol. 2014;15(5):430-7. doi: 10.2174/1389201015666140519095304.
6
Molecular mechanisms and clinical implications of miRNAs in drug resistance of esophageal cancer.
Expert Rev Gastroenterol Hepatol. 2017 Dec;11(12):1151-1163. doi: 10.1080/17474124.2017.1372189. Epub 2017 Aug 30.
7
miRNA-based biomarkers, therapies, and resistance in Cancer.
Int J Biol Sci. 2020 Jul 19;16(14):2628-2647. doi: 10.7150/ijbs.47203. eCollection 2020.
8
MicroRNAs: biogenesis, roles for carcinogenesis and as potential biomarkers for cancer diagnosis and prognosis.
Asian Pac J Cancer Prev. 2014;15(18):7489-97. doi: 10.7314/apjcp.2014.15.18.7489.
9
OncomicroRNAs-Mediated Tumorigenesis: Implication in Cancer Diagnosis and Targeted Therapy.
Curr Cancer Drug Targets. 2017;17(1):40-47. doi: 10.2174/1568009616666160216130608.
10
Micro-RNAs: The new potential biomarkers in cancer diagnosis, prognosis and cancer therapy.
Cell Mol Biol (Noisy-le-grand). 2015 Oct 16;61(5):1-10.
引用本文的文献
1
Human mesenchymal stroma/stem-like cell-derived taxol-loaded EVs/exosomes transfer anti-tumor microRNA signatures and express enhanced SDF-1-mediated tumor tropism.
Cell Commun Signal. 2024 Oct 17;22(1):506. doi: 10.1186/s12964-024-01886-2.
2
Multi-Drug Resistance against Second-Line Medication and MicroRNA Plasma Level in Metastatic Breast Cancer Patients.
Iran J Med Sci. 2023 Mar;48(2):146-155. doi: 10.30476/IJMS.2022.92604.2391.
3
Molecular Landscape of Small Bowel Adenocarcinoma.
Cancers (Basel). 2022 Mar 2;14(5):1287. doi: 10.3390/cancers14051287.
4
miR-3132 upregulates surface TRAIL to induce apoptotic cell death in cancer cells.
Am J Cancer Res. 2022 Jan 15;12(1):315-326. eCollection 2022.
5
Prediction methods for microRNA targets in bilaterian animals: Toward a better understanding by biologists.
Comput Struct Biotechnol J. 2021 Oct 18;19:5811-5825. doi: 10.1016/j.csbj.2021.10.025. eCollection 2021.
6
SNHG12 promotes carcinogenesis of human renal cell cancer via functioning as a competing endogenous RNA and sponging miR-30a-3p.
J Cell Mol Med. 2021 May;25(10):4696-4708. doi: 10.1111/jcmm.16417. Epub 2021 Mar 30.
7
microRNA-214 Prevents Traits of Cutaneous Squamous Cell Carcinoma via VEGFA and Bcl-2.
Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820980098. doi: 10.1177/1533033820980098.
8
Knockdown of Inhibits Papillary Thyroid Carcinoma Cell Invasion and Metastasis by Targeting miR-375.
Cancer Manag Res. 2020 Sep 22;12:8757-8771. doi: 10.2147/CMAR.S243767. eCollection 2020.
9
Limonoid compounds from Xylocarpus granatum and their anticancer activity against esophageal cancer cells.
Thorac Cancer. 2020 Jul;11(7):1817-1826. doi: 10.1111/1759-7714.13455. Epub 2020 May 25.
10
Chemoresistance-Associated Silencing of miR-4454 Promotes Colorectal Cancer Aggression through the and Pathway.
Cancers (Basel). 2020 May 14;12(5):1231. doi: 10.3390/cancers12051231.
本文引用的文献
1
Tumor-associated circulating microRNAs as biomarkers of cancer.
Molecules. 2014 Feb 10;19(2):1912-38. doi: 10.3390/molecules19021912.
2
Clinical relevance of circulating cell-free microRNAs in cancer.
Nat Rev Clin Oncol. 2014 Mar;11(3):145-56. doi: 10.1038/nrclinonc.2014.5. Epub 2014 Feb 4.
3
Identification of circulating microRNAs as novel potential biomarkers for gastric cancer detection: a systematic review and meta-analysis.
Dig Dis Sci. 2014 May;59(5):911-9. doi: 10.1007/s10620-013-2970-9. Epub 2013 Dec 12.
4
Ionizing radiation-inducible miR-494 promotes glioma cell invasion through EGFR stabilization by targeting p190B rhoGAP.
Biochim Biophys Acta. 2014 Mar;1843(3):508-16. doi: 10.1016/j.bbamcr.2013.11.021.
5
Upregulated microRNA-301a in breast cancer promotes tumor metastasis by targeting PTEN and activating Wnt/β-catenin signaling.
Gene. 2014 Feb 10;535(2):191-7. doi: 10.1016/j.gene.2013.11.035. Epub 2013 Dec 4.
6
Targeting miR-21 enhances the sensitivity of human colon cancer HT-29 cells to chemoradiotherapy in vitro.
Biochem Biophys Res Commun. 2014 Jan 17;443(3):789-95. doi: 10.1016/j.bbrc.2013.11.064. Epub 2013 Nov 23.
7
Down-regulation of miR-221 inhibits proliferation of pancreatic cancer cells through up-regulation of PTEN, p27(kip1), p57(kip2), and PUMA.
Am J Cancer Res. 2013 Nov 1;3(5):465-77. eCollection 2013.
8
MicroRNA-106b-5p boosts glioma tumorigensis by targeting multiple tumor suppressor genes.
Oncogene. 2014 Oct 2;33(40):4813-22. doi: 10.1038/onc.2013.428. Epub 2013 Oct 28.
9
MicroRNA-205 suppresses the oral carcinoma oncogenic activity via down-regulation of Axin-2 in KB human oral cancer cell.
Mol Cell Biochem. 2014 Feb;387(1-2):71-9. doi: 10.1007/s11010-013-1872-7. Epub 2013 Oct 29.
10
MiR-145 is downregulated in human ovarian cancer and modulates cell growth and invasion by targeting p70S6K1 and MUC1.
Biochem Biophys Res Commun. 2013 Nov 29;441(4):693-700. doi: 10.1016/j.bbrc.2013.10.053. Epub 2013 Oct 21.
Zotero 插件